文献速递泌尿生殖腹部US

与肾脏在所有血管期呈等增强的实性肾肿瘤:与假性肿块的鉴别

Solid Renal Tumors Isoenhancing to Kidneys on Contrast-Enhanced Sonography: Differentiation From Pseudomasses.
PubMed 文献 · J Ultrasound Med · 2017-07-29

回顾性分析3家机构380例实性肿瘤和31例假性肿块,5%(19/380)的实性肿瘤在超声造影所有血管期与肾脏呈等增强;结合灰阶超声特征和血管特征,2名放射科医师可将此类肿瘤与假性肿块鉴别,AUC分别为0.997和0.969,读者间一致性很好(加权κ=0.81)。

要点

  • 超声造影所有血管期与肾脏等增强的实性肾肿瘤约占5%(19/380),需与假性肿块鉴别。
  • 结合灰阶超声特征(回声、肾髓质是否可见)和血管特征可鉴别,AUC达0.997和0.969。
  • 假性肿块多与肾脏等回声(23/31),两名医师分别有1例和2例将假性肿块判为肿瘤。

核心结论

  • 回顾性研究显示5%的实性肾肿瘤在所有血管期与肾脏等增强,通过观察基线超声特征和血管特征可与假性肿块鉴别。

研究设计与样本

  • 回顾性研究,计算机检索3家机构数据库,纳入31例假性肿块和380例实性肿瘤,均行超声造影检查;由2名放射科医师盲法评估图像和视频剪辑。

关键影像表现/征象

  • 等增强肿瘤包括透明细胞癌7例、血管平滑肌脂肪瘤3例、乳头状肿瘤3例、转移瘤1例、嗜酸细胞瘤1例。
  • 4例未手术肿瘤通过随访进展确诊。
  • 肿块回声:明显高回声3例、轻度低/高回声11例、等回声5例。
  • 假性肿块中23/31与肾脏等回声;医师1和医师2分别有22/31和15/31可见肾髓质。
  • 医师1和医师2分别将1例和2例假性肿块判为肿瘤;1例等回声等增强肿瘤在超声造影上未被识别。

诊断标准与关键数值

  • 联合灰阶超声和超声造影鉴别等增强肿瘤与假性肿块的AUC:医师1为0.997,医师2为0.969。
  • 读者间一致性加权κ=0.81。

临床应用与阅片要点

  • 对超声造影所有血管期与肾脏等增强的实性肾肿瘤,应结合基线灰阶超声特征(回声水平、肾髓质是否可见)和血管特征与假性肿块鉴别。

局限性

  • 原文为回顾性研究。
  • 部分肿瘤(4例)未手术,诊断经随访进展确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To estimate the prevalence of solid renal tumors isoenhancing to kidneys in all vascular phases on contrast-enhanced sonography and to investigate whether they can be differentiated from pseudomasses.

METHODS: A computer search of the databases of 3 institutions identified 31 patients with pseudomasses and 380 patients with solid tumors investigated with contrast-enhanced sonography. Nineteen of 380 (5%) patients had tumors isoenhancing in all phases. Images and clips of these 19 tumors and the 31 pseudomasses were blindly assessed by 2 radiologists. They were asked to differentiate tumors from pseudomasses based on echogenicity, vascular architecture, and the presence of the medulla.

RESULTS: Isoenhancing tumors were clear cell carcinomas (n = 7), angiomyolipomas (n = 3), papillary tumors (n = 3), metastasis (n = 1), and oncocytoma (n = 1). In the 4 nonoperated tumors, the diagnosis was confirmed by progression during the follow-up. There were 3 markedly hyperechoic, 11 mildly hypo/hyperechoic, and 5 isoechoic masses. Most pseudomasses were isoechoic to kidneys (23 of 31), with the medulla identified in 22 of 31 and 15 of 31 by radiologists 1 and 2, respectively. One and 2 pseudomasses were considered tumors by radiologists 1 and 2, respectively. One isoechoic isoenhancing tumor was not identified on contrast-enhanced sonography. Isoenhancing tumors in all phases were differentiated from pseudomasses by combining grayscale and contrast-enhanced sonography (areas under the receiver operating characteristic curve, 0.997 for reader 1; 0.969 for reader 2), with very good inter-reader agreement (weighted κ = 0.81).

CONCLUSIONS: In our retrospective study, 5% of solid renal lesions were isoenhancing to kidneys in all phases. Differentiation from pseudomasses was possible by looking at baseline sonographic features and vascular characteristics.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Bertolotto M, Cicero C, Catalano O, et al. Solid Renal Tumors Isoenhancing to Kidneys on Contrast-Enhanced Sonography: Differentiation From Pseudomasses. J Ultrasound Med. 2017. PMID: 28755508. doi:10.1002/jum.14335

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。